Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Rankin

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|February 1, 1992
A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancerE M Rankin, L Mill, S B Kaye, et al.
Cancer Research|December 15, 1987
Phase I and pharmacokinetic study of flavone acetic acidD J Kerr, S B Kaye, J Cassidy, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1995
Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19L T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trialT Habeshaw, J Paul, R Jones, et al.
Hematological Oncology|January 1, 1990
The myelotoxicity of carboplatin is influenced by the time of its administrationD J Kerr, C Lewis, B O'Neil, et al.
British Journal of Cancer|May 1, 1992
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspectsL T Vlasveld, E M Rankin, A Hekman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervixR E Coleman, P G Harper, C Gallagher, et al.
Lancet (London, England)|August 8, 1992
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerS B Kaye, C R Lewis, J Paul, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1994
Report of a symposium on: diagnosis and treatment of cutaneous head and neck melanomaA J Balm, B B Kroon, J B de Boer, et al.
British Journal of Cancer|September 1, 1993
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspectsL T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|February 1, 1992
A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancerE M Rankin, L Mill, S B Kaye, et al.
Cancer Research|December 15, 1987
Phase I and pharmacokinetic study of flavone acetic acidD J Kerr, S B Kaye, J Cassidy, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1995
Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19L T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trialT Habeshaw, J Paul, R Jones, et al.
Hematological Oncology|January 1, 1990
The myelotoxicity of carboplatin is influenced by the time of its administrationD J Kerr, C Lewis, B O'Neil, et al.
British Journal of Cancer|May 1, 1992
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspectsL T Vlasveld, E M Rankin, A Hekman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervixR E Coleman, P G Harper, C Gallagher, et al.
Lancet (London, England)|August 8, 1992
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerS B Kaye, C R Lewis, J Paul, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1994
Report of a symposium on: diagnosis and treatment of cutaneous head and neck melanomaA J Balm, B B Kroon, J B de Boer, et al.
British Journal of Cancer|September 1, 1993
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspectsL T Vlasveld, A Hekman, F A Vyth-Dreese, et al.
Pageof 6